Travel vaccination for rabies

References

• Hemachudha T, Wacharapluesadee S, Mitrabhakdi E et al. Pathophysiology of human paralytic rabies. J. Neurovirol.11(1), 93–100 (2005).
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Burton EC, Kuehnert MJ et al. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med.352(11), 1103–1111 (2005).
   PubMed Web of Science ®Google Scholar
• Hellenbrand W, Meyer C, Rasch G, Steffens I, Ammon A. Cases of rabies in Germany following organ transplantation. Euro Surveill.10(2), E050224–050226 (2005).
   Google Scholar
• Houff SA, Burton RC, Wilson RW et al. Human-to-human transmission of rabies virus by corneal transplant. N. Engl. J. Med.300(11), 603–604 (1979).
   PubMed Web of Science ®Google Scholar
• Briggs DJ. Human rabies vaccines. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 505–515 (2007).
   Google Scholar
• Baer GM. The history of rabies. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 1–22 (2007).
   Google Scholar
• US CDC. Human rabies prevention – United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.48(RR-1), 1–21 (1999).
   Google Scholar
• Nadin-Davis SA. Molecular epidemiology. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 69–115 (2007).
   Google Scholar
• Lumlertdacha B, Boongird K, Wanghongsa S et al. Survey for bat lyssaviruses, Thailand. Emerg. Infect. Dis.11(2), 232–236 (2005).
   PubMed Web of Science ®Google Scholar
• Kuzmin IV, Niezgoda M, Franka R et al. Lagos bat virus in Kenya. J. Clin. Microbiol.46(4), 1451–1461 (2008).
   PubMedGoogle Scholar
• Hanlon CA, Kuzmin IV, Blanton JD et al. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res.111(1), 44–54 (2005).
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Willoughby R, Slate D. Current and future trends in the prevention, treatment and control of rabies. Expert Rev. Anti Infect. Ther.4(6), 1021–1038 (2006).
   PubMedGoogle Scholar
• Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J. Am. Vet. Med. Assoc.231(4), 540–556 (2007).
   PubMedGoogle Scholar
• Kuzmin I, Rupprecht C. Bat rabies. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 259–307 (2007).
   Google Scholar
• Tamashiro H, Matibag GC, Ditangco RA, Kanda K, Ohbayashi Y. Revisiting rabies in Japan: is there cause for alarm? Travel Med. Infect. Dis.5(5), 263–275 (2007).
   PubMedGoogle Scholar
• Identification of a rabid dog in France illegally introduced from Morocco. Euro Surveill.13(11), 8066 (2008).
   PubMedGoogle Scholar
• WHO. WHO Expert consultation on rabies. First report. In: WHO Technical Report Series No 931. WHO, Geneva, Switzerland 121 (2004).
   Google Scholar
• Aubert MF. Costs and benefits of rabies control in wildlife in France. Rev. Sci. Tech.18(2), 533–543 (1999).
   PubMedGoogle Scholar
• Meslin F-X, Kaplan MM. General considerations in the production and use of brain-tissue and purified chicken-embryo rabies vaccines for human use. In: Laboratory Techniques in Rabies. Meslin F-X, Kaplan MM, Koprowski H (Eds) WHO, Geneva, Switzerland 204–212 (1996).
   Google Scholar
• WHO. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. In: WHO Technical Report Series, No 941. WHO, Geneva, Switzerland 50– (2007).
   Google Scholar
• Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In: Vaccines. Plotkin SA, Orenstein W, Offit P (Eds) Elsevier, London, UK 687–714 (2008).
   Google Scholar
• Mahendra BJ, Madhusudana SN, Ashwathnarayana DH et al. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers. Vaccine25(50), 8405–8409 (2007).
   PubMed Web of Science ®Google Scholar
• Khawplod P, Glueck R, Wilde H et al. Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen. Clin. Infect. Dis.20(3), 646–651 (1995).
   PubMedGoogle Scholar
• Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am. J. Trop. Med. Hyg.42(2), 175–178 (1990).
   PubMedGoogle Scholar
• CDC. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP). MMWR Recomm. Rep.40(RR-10), 1–28 (1991).
   PubMedGoogle Scholar
• Wilde H, Tipkong P, Khawplod P. Economic issues in postexposure rabies treatment. J. Travel Med.6(4), 238–242 (1999).
   PubMed Web of Science ®Google Scholar
• Phanuphak P, Khawplod P, Sirivichayakul S et al. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac. J. Allergy Immunol.5(1), 33–37 (1987).
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Riddell A, Yu LM et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl. Trop. Dis.2(4), e224 (2008).
   PubMed Web of Science ®Google Scholar
• Noah DL, Drenzek CL, Smith JS et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med.128(11), 922–930 (1998).
   PubMed Web of Science ®Google Scholar
• Human rabies – New Hampshire, 1996. MMWR Morb. Mortal. Wkly Rep.46(12), 267–270 (1997).
   PubMedGoogle Scholar
• US CDC. CDC Health Information for International Travel 2008. US Department of Health and Human Services, Public Health Service, GA, USA (2007).
   Google Scholar
• LeGuerrier P, Pilon PA, Deshaies D, Allard R. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis. Vaccine14(2), 167–176 (1996).
   PubMedGoogle Scholar
• Bernard KW, Fishbein DB. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine9(11), 833–836 (1991).
   PubMedGoogle Scholar
• Pancharoen C, Thisyakorn U, Tantawichien T et al. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand. J. Infect. Dis.33(5), 390–391 (2001).
   PubMedGoogle Scholar
• Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin. Infect. Dis.33(10), E122–E124 (2001).
   PubMed Web of Science ®Google Scholar
• Hay E, Derazon H, Bukish N, Scharf S, Rishpon S. Postexposure rabies prophylaxis in a patient with lymphoma. JAMA285(2), 166–167 (2001).
   PubMedGoogle Scholar
• Blanton JD, Bowden NY, Eidson M, Wyatt JD, Hanlon CA. Rabies postexposure prophylaxis, New York, 1995–2000. Emerg. Infect. Dis.11(12), 1921–1927 (2005).
   PubMedGoogle Scholar
• Willoughby RE Jr, Tieves KS, Hoffman GM et al. Survival after treatment of rabies with induction of coma. N. Engl. J. Med.352(24), 2508–2514 (2005).
   PubMed Web of Science ®Google Scholar
• Briggs D, Hanlon CA. World Rabies Day: focusing attention on a neglected disease. Vet. Rec.161(9), 288–289 (2007).
   PubMedGoogle Scholar
• Dedmon R. Mad dogs and Englishmen. Asian Biomedicine2(1), 1–8 (2008).
   Google Scholar
• Sugiyama M, Ito N. Control of rabies: epidemiology of rabies in Asia and development of new-generation vaccines for rabies. Comp. Immunol. Microbiol. Infect. Dis.30(5–6), 273–286 (2007).
   PubMed Web of Science ®Google Scholar
• Schneider MC, Belotto A, Ade MP et al. Current status of human rabies transmitted by dogs in Latin America. Cad Saude Publica23(9), 2049–2063 (2007).
   PubMed Web of Science ®Google Scholar
• Costa WA, Cunha RS, Bolzan VL et al. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Vaccine25(48), 8140–8145 (2007).
   PubMedGoogle Scholar
• Kulkarni PS, Raut SK, Jadhav SS, Kapre SV, Deuskar N. Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis. Hum. Vaccin.3(5), 183–186 (2007).
   PubMed Web of Science ®Google Scholar
• Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine24(19), 4116–4121 (2006).
   PubMed Web of Science ®Google Scholar
• Parkinson AJ, Butler JC. Potential impacts of climate change on infectious diseases in the Arctic. Int. J. Circumpolar Health64(5), 478–486 (2005).
   PubMedGoogle Scholar
• Welbergen JA, Klose SM, Markus N, Eby P. Climate change and the effects of temperature extremes on Australian flying-foxes. Proc. Biol. Sci.275(1633), 419–425 (2008).
   PubMed Web of Science ®Google Scholar
• Tordo N, Bahloul C, Jacob Y et al. Rabies: epidemiological tendencies and control tools. Dev. Biol. (Basel)125, 3–13 (2006).
   PubMedGoogle Scholar